EGFR and persistent hyperplastic primary vitreous: What is more, the impaired EGFR-MTORC1-autophagy signaling may adversely affect the vascular remodeling processes essential to regression of the fetal vasculature, which can be rescued by an EGFR inhibitor of gefitinib in vivo to serve as a novel therapy for PHPV disease [12].